Satellos Bioscience Inc
Officers & Directors
Geoff MacKay has served as Board Chair since July 2018 and as CEO of Fable Therapeutics since 2023. He was previously CEO of Avrobio from 2015 to 2023. Frank Gleeson has been a Director since July 2012, President since April 2018, and CEO since March 2018; he is also CEO of Satellos Bioscience Inc. since 2018. Selwyn Ho has been a Director since June 18, 2025, and CEO of Signadori Bio since 2025; he was CEO of Medigene AG from 2022 to 2025. Iris Loew-Friedrich has served as a Director since June 18, 2025, has been self-employed since 2024, and was Chief Medical Officer at UCB SA from 2008 to 2024. Brian Bloom has been a Director since March 2018 and CEO of Bloom Burton & Co. since 2008. Mark Nawacki has been a Director since November 14, 2025, and President of Searchlight Pharma Inc. since 2015. Adam Mostafa has served as a Director since December 5, 2021, is CFO of Sitryx Pharmaceuticals since 2025, and was CFO of X4 Pharmaceuticals from 2018 to 2025. Franklin Berger has been a Director since June 29, 2023, and an entrepreneur since 2012. Stephanie Brown has been a Director since November 12, 2024, and was President North America at Santhera Pharmaceutical from 2021 to 2024. Dr. Michael Rudnicki has been Chief Discovery Officer since August 13, 2021, and a Senior Scientist at OHRI since 2000. Elizabeth Williams has served as Chief Financial Officer since September 1, 2023, is CFO of Satellos Bioscience Inc. since 2023, and was CFO of Medicenna Therapeutic from 2016 to 2023. Dr. Phil Lambert has been Chief Scientific Officer since September 28, 2022, and CTO of Satellos Bioscience Inc. since 2022. Dr. Wildon Farwell has served as Chief Medical Officer since July 16, 2025, is CMO of Satellos Bioscience Inc. since 2025, and was CMO of Dyne Therapeutics from 2021 to 2025.
|
